Glatiramer Acetate 40 Mg/Ml Three Times A Week for The Treatment of Relapsing Forms of Multiple Sclerosis- Potential Cost Benefits of A Regimen With Infrequent Injections Which May Minimise Switching to The Newly-Introduced First-Line and S ...
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.2908
https://www.valueinhealthjournal.com/article/S1098-3015(15)04989-X/fulltext
Title :
Glatiramer Acetate 40 Mg/Ml Three Times A Week for The Treatment of Relapsing Forms of Multiple Sclerosis- Potential Cost Benefits of A Regimen With Infrequent Injections Which May Minimise Switching to The Newly-Introduced First-Line and S ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04989-X&doi=10.1016/j.jval.2015.09.2908
First page :
A751
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
2310